![]()
|
|
||||||||
J. Biol. Chem., Vol. 278, Issue 49, 48794-48804, December 5, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Attenuates Contractions by Decreasing the Activities of CPI-17 and MYPT-1 in Intestinal Smooth Muscle*


From the
Department of Veterinary Pharmacology and
Radioisotope Center, Graduate School of Agriculture and Life Sciences, the University of Tokyo, Yayoi 1-1-1, Bunkyo-ku, Tokyo 113-8657, Japan
Interleukin-1
(IL-1
) is a proinflammatory cytokine that plays a central role in inflammatory bowel disease (IBD). In order to elucidate the mechanism of motility disorders frequently observed in IBD, we investigated the long term effects of IL-1
on rat ileal smooth muscle contractility by using an organ culture system. When ileal smooth muscle strips were cultured with IL-1
(10 ng/ml), contractions elicited by high K+ and carbachol were inhibited in a time-dependent manner. IL-1
more strongly inhibited the carbachol-induced contractions than high K+ with decreasing myosin light chain phosphorylation. In the
-toxin-permeabilized ileal muscle, carbachol with GTP or guanosine 5'-3-O-(thio)triphosphate increased the Ca2+ sensitivity of contractile elements, and this G protein-coupled Ca2+ sensitization was significantly reduced in the IL-1
-treated ileum. Among the functional proteins involved in the smooth muscle Ca2+ sensitization, CPI-17 expression was significantly reduced after the culture with IL-1
, whereas the expressions of RhoA, ROCK-I, ROCK-II, MYPT-1, myosin light chain kinase, and myosin phosphatase (PP1) were unchanged. The phosphorylation level of CPI-17 by carbachol was low in accordance with the decrease in CPI-17 expression due to IL-1
treatment. In contrast, constitutively phosphorylated MYPT-1 was also decreased in the IL-1
-treated muscles. These results suggest that long term treatment with IL-1
decreases either CPI-17 expression or MYPT-1 phosphorylation, which may result in an increase in myosin phosphatase activity to reduce force generation. Based on these findings, we consider IL-1
to be an important mediator of gastrointestinal motility disorders in IBD, and CPI-17 and MYPT-1 are key molecules in the decreased smooth muscle contractility due to IL-1
.
Received for publication, September 12, 2003
* This work was supported by the Program for the Promotion of Basic Research Activities for Innovative Biosciences, The Yakult Foundation, Morinaga Hoshi-kai, and a Grant-in-aid for Scientific Research from the Japanese Ministry of Education, Culture, and Science. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence should be addressed: Dept. of Veterinary Pharmacology, Graduate School of Agriculture and Life Sciences, the University of Tokyo, Yayoi 1-1-1, Bunkyo-ku, Tokyo 113-8657, Japan. Tel.: 81-3-5841-5393; Fax: 81-3-58411-8183.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
Y. Mizuno, E. Isotani, J. Huang, H. Ding, J. T. Stull, and K. E. Kamm Myosin light chain kinase activation and calcium sensitization in smooth muscle in vivo Am J Physiol Cell Physiol, August 1, 2008; 295(2): C358 - C364. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Hu, S. Mahavadi, F. Li, and K. S. Murthy Upregulation of RGS4 and downregulation of CPI-17 mediate inhibition of colonic muscle contraction by interleukin-1 Am J Physiol Cell Physiol, December 1, 2007; 293(6): C1991 - C2000. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ohama, M. Hori, E. Momotani, M. Elorza, W. T. Gerthoffer, and H. Ozaki IL-1beta inhibits intestinal smooth muscle proliferation in an organ culture system: involvement of COX-2 and iNOS induction in muscularis resident macrophages Am J Physiol Gastrointest Liver Physiol, May 1, 2007; 292(5): G1315 - G1322. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ohama, M. Hori, E. Momotani, Y. Iwakura, F. Guo, H. Kishi, S. Kobayashi, and H. Ozaki Intestinal inflammation downregulates smooth muscle CPI-17 through induction of TNF-{alpha} and causes motility disorders Am J Physiol Gastrointest Liver Physiol, May 1, 2007; 292(5): G1429 - G1438. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Pang, Z. Guo, Z. Xie, W. Su, and M. C. Gong Divergent kinase signaling mediates agonist-induced phosphorylation of phosphatase inhibitory proteins PHI-1 and CPI-17 in vascular smooth muscle cells Am J Physiol Cell Physiol, March 1, 2006; 290(3): C892 - C899. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Pang, Z. Guo, W. Su, Z. Xie, M. Eto, and M. C. Gong RhoA-Rho kinase pathway mediates thrombin- and U-46619-induced phosphorylation of a myosin phosphatase inhibitor, CPI-17, in vascular smooth muscle cells Am J Physiol Cell Physiol, August 1, 2005; 289(2): C352 - C360. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kim, S. Y. Cho, I. S. Han, S. D. Koh, and B. A. Perrino CaM kinase II and phospholamban contribute to caffeine-induced relaxation of murine gastric fundus smooth muscle Am J Physiol Cell Physiol, June 1, 2005; 288(6): C1202 - C1210. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. H. Ratz, K. M. Berg, N. H. Urban, and A. S. Miner Regulation of smooth muscle calcium sensitivity: KCl as a calcium-sensitizing stimulus Am J Physiol Cell Physiol, April 1, 2005; 288(4): C769 - C783. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Bonnevier and A. Arner Actions Downstream of Cyclic GMP/Protein Kinase G Can Reverse Protein Kinase C-mediated Phosphorylation of CPI-17 and Ca2+Sensitization in Smooth Muscle J. Biol. Chem., July 9, 2004; 279(28): 28998 - 29003. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |